July 21, 2009 (FinancialWire) — The Quigley Corp., (NASDAQ: QGLY) said that Ted Karkus, the chairman of the company’s board, has been appointed as Quigley’s chief executive officer. Robert V. Cuddihy, Jr. has been appointed chief operating officer.

Karkus recently conducted a successful proxy contest that resulted in his slate of directors being elected to the Quigley board. He had been serving as interim CEO since June 12. Karkus, a 25 year Wall Street veteran, has been providing management consulting services to emerging-growth companies since 1996.

Cuddihy, Jr. formerly served in senior roles at HMG Worldwide, which focused on retail, planning and merchandising, and iDNA Inc. that focused on corporate communications.

He most recently served as the president of Shannon Hill Associates, providing due diligence, financial structuring, and transaction negotiation services for M&A, restructurings and divestitures.

Doylestown, Pennsylvania-based Quigley is a natural health medical science company. The company’s Cold Remedy segment is a marketer and manufacturer of the Cold-Eeze line of lozenges, gums and sugar free tablets clinically proven to cut the common cold nearly in half.

The company’s Cold-Eeze customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.